Highview Capital Management LLC DE Takes $287,000 Position in The Cigna Group (NYSE:CI)

Highview Capital Management LLC DE bought a new position in The Cigna Group (NYSE:CI - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 1,040 shares of the health services provider's stock, valued at approximately $287,000.

Several other institutional investors and hedge funds also recently made changes to their positions in CI. TCTC Holdings LLC bought a new position in The Cigna Group during the 4th quarter worth approximately $25,000. Collier Financial acquired a new stake in The Cigna Group in the 4th quarter valued at $32,000. Compagnie Lombard Odier SCmA acquired a new stake in The Cigna Group in the 4th quarter valued at $37,000. Transce3nd LLC acquired a new stake in The Cigna Group in the 4th quarter valued at $38,000. Finally, Heck Capital Advisors LLC purchased a new position in The Cigna Group during the 4th quarter worth $53,000. Institutional investors and hedge funds own 86.99% of the company's stock.

The Cigna Group Trading Down 0.3%

NYSE CI traded down $0.81 on Tuesday, hitting $315.18. The company's stock had a trading volume of 492,930 shares, compared to its average volume of 1,711,641. The company has a current ratio of 0.66, a quick ratio of 0.72 and a debt-to-equity ratio of 0.70. The Cigna Group has a 52-week low of $262.03 and a 52-week high of $370.83. The firm has a market cap of $84.20 billion, a P/E ratio of 25.75, a PEG ratio of 0.98 and a beta of 0.47. The company's 50-day simple moving average is $325.26 and its 200 day simple moving average is $309.92.

The Cigna Group (NYSE:CI - Get Free Report) last issued its quarterly earnings data on Friday, May 2nd. The health services provider reported $6.74 EPS for the quarter, topping the consensus estimate of $6.35 by $0.39. The Cigna Group had a net margin of 1.39% and a return on equity of 18.61%. The business had revenue of $65.45 billion during the quarter, compared to analyst estimates of $60.39 billion. During the same period in the prior year, the business earned $6.47 EPS. The company's revenue for the quarter was up 14.4% on a year-over-year basis. Research analysts predict that The Cigna Group will post 29.77 EPS for the current fiscal year.

The Cigna Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, June 18th. Investors of record on Tuesday, June 3rd will be paid a $1.51 dividend. The ex-dividend date is Tuesday, June 3rd. This represents a $6.04 annualized dividend and a dividend yield of 1.92%. The Cigna Group's payout ratio is 33.44%.

Analysts Set New Price Targets

A number of equities analysts have issued reports on CI shares. Oppenheimer cut their price objective on shares of The Cigna Group from $400.00 to $375.00 and set an "outperform" rating on the stock in a report on Friday, January 31st. Morgan Stanley boosted their price objective on The Cigna Group from $379.00 to $390.00 and gave the company an "overweight" rating in a research note on Monday, May 5th. Mizuho upped their price target on The Cigna Group from $360.00 to $384.00 and gave the company an "outperform" rating in a research report on Wednesday, April 9th. Barclays boosted their price objective on shares of The Cigna Group from $339.00 to $382.00 and gave the company an "overweight" rating in a research note on Monday, May 5th. Finally, Raymond James reissued a "strong-buy" rating and issued a $360.00 price target (down previously from $415.00) on shares of The Cigna Group in a research note on Friday, January 31st. Two analysts have rated the stock with a hold rating, sixteen have assigned a buy rating and three have issued a strong buy rating to the company's stock. According to MarketBeat, The Cigna Group currently has a consensus rating of "Buy" and an average target price of $379.33.

Insider Buying and Selling

In related news, insider Nicole S. Jones sold 4,904 shares of the stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $308.12, for a total transaction of $1,511,020.48. Following the sale, the insider now directly owns 29,421 shares of the company's stock, valued at approximately $9,065,198.52. This represents a 14.29% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO David Cordani sold 26,527 shares of the stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $308.12, for a total transaction of $8,173,499.24. Following the sale, the chief executive officer now directly owns 127,767 shares in the company, valued at $39,367,568.04. This trade represents a 17.19% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 43,751 shares of company stock worth $13,603,991 in the last three months. 0.70% of the stock is owned by corporate insiders.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.